Illumina, Inc.
NASDAQ: ILMN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jacob Thaysen
- Employees
- 8,970
- Headquarters
- San Diego, United States
- IPO year
- 2000
- Market cap
- $24.5B
- Website
- https://www.illumina.com
Loading ILMN…
Loading profile data…Frequently asked questions about ILMN
What does Illumina, Inc. (ILMN) do?
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer...
Where does ILMN trade?
Illumina, Inc. (ILMN) trades on the NASDAQ Global Select.
What sector is ILMN in?
Illumina, Inc. (ILMN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Illumina, Inc.?
Jacob Thaysen is the chief executive officer of Illumina, Inc. (ILMN).
Where is Illumina, Inc. headquartered?
Illumina, Inc. is headquartered in United States.
Does ILMN pay a dividend?
Illumina, Inc. (ILMN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ILMN go public?
Illumina, Inc. (ILMN) completed its initial public offering in 2000.